Trial intelligence / Profile preview

PRP, Glucocorticoid, and Saline Injection for Lateral Epicondylitis

NCT04875338Phase 3Completed

Sponsor
Istanbul University
Start
Jan 2021
Primary completion
Jan 2023
Modality
Adipose-derived MSCs, Orthosteric Ligands, Bone Marrow MSCs
Countries
1
01

Overview

A Phase 3 trial of platelet-rich plasma, betamethasone in Lateral Epicondylitis (LET), sponsored by Istanbul University. Started Jan 2021; status: completed.

02

Drugs

platelet-rich plasmabetamethasone
03

Conditions

Lateral Epicondylitis (LET)

Beyond the preview

Go deeper on NCT04875338.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04875338.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call